DC Circ. Won't Add To Novo Nordisk Whistleblower's Payout
The D.C. Circuit ruled Tuesday that a whistleblower who keyed the federal government into Novo Nordisk's alleged practice of misleading physicians and insurers about its diabetes drug Victoza can pull in...To view the full article, register now.
Already a subscriber? Click here to view full article